Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.
| Image |  |
|---|---|
| Description | scientific article published on 8 May 2017 |
| Author/s |
author: Mark Ward Jeremy Sanderson Peter Irving John Reynolds |
| Publication date | May 8, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |